Photo of Boris Hartmann

Boris Hartmann

Print ProfilePrint Profile


BorderĂ­a AV, Hartmann BM, Fernandez-Sesma A, Moran TM, Sealfon SC. Antiviral-activated dendritic cells: a paracrine-induced response state. Journal of immunology (Baltimore, Md. : 1950) 2008 Nov; 181(10).


Hartmann B, Staedtler F, Hartmann N, Meingassner J, Firat H. Gene expression profiling of skin and draining lymph nodes of rats affected with cutaneous contact hypersensitivity. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2006 Aug; 55(8).

Qiao L, Phipps-Yonas H, Hartmann B, Moran TM, Sealfon SC, Hayot F. Immune response modeling of interferon beta-pretreated influenza virus-infected human dendritic cells. Biophysical journal 2010 Feb; 98(4).

Bavandi A, Fahrngruber H, Aschauer H, Hartmann B, Meingassner JG, Kalthoff FS. Pimecrolimus and tacrolimus differ in their inhibition of lymphocyte activation during the sensitization phase of contact hypersensitivity. Journal of dermatological science 2006 Aug; 43(2).

Phipps-Yonas H, Jiang K, Hartmann BM, Ge Y, Sealfon SC, Moran TM. A comprehensive evaluation of human plasmacytoid dendritic cells using small volumes of human blood. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2008 Aug; 28(8).

Arsov I, Li X, Matthews G, Coradin J, Hartmann B, Simon AK, Sealfon SC, Yue Z. BAC-mediated transgenic expression of fluorescent autophagic protein Beclin 1 reveals a role for Beclin 1 in lymphocyte development. Cell death and differentiation 2008 Sep; 15(9).

Gardete S, Kim C, Hartmann BM, Mwangi M, Roux CM, Dunman PM, Chambers HF, Tomasz A. Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant Staphylococcus aureus (MRSA) strain of clonal type USA300. PLoS pathogens 2012 Feb; 8(2).

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Hartmann did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central


Annenberg Building Floor 14 Room 211C
1468 Madison Avenue
New York, NY 10029


Annenberg Building Floor 14 Room 83
1468 Madison Avenue
New York, NY 10029

Tel: 646-724-3861